BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 20842542)

  • 1. Modified nanoprecipitation method for preparation of cytarabine-loaded PLGA nanoparticles.
    Yadav KS; Sawant KK
    AAPS PharmSciTech; 2010 Sep; 11(3):1456-65. PubMed ID: 20842542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation optimization of etoposide loaded PLGA nanoparticles by double factorial design and their evaluation.
    Yadav KS; Sawant KK
    Curr Drug Deliv; 2010 Jan; 7(1):51-64. PubMed ID: 20044908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nimodipine loaded PLGA nanoparticles: formulation optimization using factorial design, characterization and in vitro evaluation.
    Mehta AK; Yadav KS; Sawant KK
    Curr Drug Deliv; 2007 Jul; 4(3):185-93. PubMed ID: 17627492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long circulating PEGylated PLGA nanoparticles of cytarabine for targeting leukemia.
    Yadav KS; Jacob S; Sachdeva G; Chuttani K; Mishra AK; Sawant KK
    J Microencapsul; 2011; 28(8):729-42. PubMed ID: 21970655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles.
    Niu X; Zou W; Liu C; Zhang N; Fu C
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1375-83. PubMed ID: 19832638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doxorubicin-loaded star-shaped copolymer PLGA-vitamin E TPGS nanoparticles for lung cancer therapy.
    Zhang J; Tao W; Chen Y; Chang D; Wang T; Zhang X; Mei L; Zeng X; Huang L
    J Mater Sci Mater Med; 2015 Apr; 26(4):165. PubMed ID: 25791459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyrotropin-Releasing Hormone Loaded and Chitosan Engineered Polymeric Nanoparticles: Towards Effective Delivery of Neuropeptides.
    Kaur S; Bhararia A; Sharma K; Mittal S; Jain R; Wangoo N; Sharma RK
    J Nanosci Nanotechnol; 2016 May; 16(5):5324-32. PubMed ID: 27483926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation and in vitro characterization of Eudragit® L100 and Eudragit® L100-PLGA nanoparticles containing diclofenac sodium.
    Cetin M; Atila A; Kadioglu Y
    AAPS PharmSciTech; 2010 Sep; 11(3):1250-6. PubMed ID: 20697984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of biodegradable polymeric nanoparticles and their controlled drug delivery for tuberculosis.
    Malathi S; Balasubramanian S
    J Biomed Nanotechnol; 2011 Feb; 7(1):150-1. PubMed ID: 21485846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loading and release of amphotericin-B from biodegradable poly(lactic-co-glycolic acid) nanoparticles.
    Verma RK; Pandya S; Misra A
    J Biomed Nanotechnol; 2011 Feb; 7(1):118-20. PubMed ID: 21485832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Formulation and process optimization of doxorubicin-loaded PLGA nanoparticles and its in vitro release].
    Li JL; Zheng CL; Liu JP; Zhu JB
    Yao Xue Xue Bao; 2013 May; 48(5):759-66. PubMed ID: 23888702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystalline drug aconitine-loaded poly(d,l-lactide-coglycolide) nanoparticles: preparation and in vitro release.
    Xu X; Xiang Q; He Z; Liu Y; Zhou D; Qin X; Fan T; Zhang Z; Huang Y
    Yakugaku Zasshi; 2010 Mar; 130(3):409-18. PubMed ID: 20190525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.
    Witschi C; Doelker E
    J Control Release; 1998 Feb; 51(2-3):327-41. PubMed ID: 9685930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A modified double-emulsion method for the preparation of daunorubicin-loaded polymeric nanoparticle with enhanced in vitro anti-tumor activity.
    Liu J; Qiu Z; Wang S; Zhou L; Zhang S
    Biomed Mater; 2010 Dec; 5(6):065002. PubMed ID: 20924138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poly(D,L-lactide-co-glycolide) nanoparticles encapsulated fluorescent isothiocyanate and paclitaxol: preparation, release kinetics and anticancer effect.
    Yang H; Li K; Liu Y; Liu Z; Miyoshi H
    J Nanosci Nanotechnol; 2009 Jan; 9(1):282-7. PubMed ID: 19441308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and evaluation of hyaluronic acid-coated PLGA nanoparticles of raloxifene hydrochloride for treatment of breast cancer.
    Bhatt K; Patil P; Jani P; Thakkar P; Sawant K
    Drug Dev Ind Pharm; 2021 Dec; 47(12):2013-2024. PubMed ID: 35686735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Celecoxib-loaded poly(D,L-lactide-co-glycolide) nanoparticles prepared using a novel and controllable combination of diffusion and emulsification steps as part of the salting-out procedure.
    McCarron PA; Donnelly RF; Marouf W
    J Microencapsul; 2006 Aug; 23(5):480-98. PubMed ID: 16980271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carboplatin loaded Surface modified PLGA nanoparticles: Optimization, characterization, and in vivo brain targeting studies.
    Jose S; Juna BC; Cinu TA; Jyoti H; Aleykutty NA
    Colloids Surf B Biointerfaces; 2016 Jun; 142():307-314. PubMed ID: 26970818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rivastigmine-loaded PLGA and PBCA nanoparticles: preparation, optimization, characterization, in vitro and pharmacodynamic studies.
    Joshi SA; Chavhan SS; Sawant KK
    Eur J Pharm Biopharm; 2010 Oct; 76(2):189-99. PubMed ID: 20637869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability and freeze-drying of cyclosporine loaded poly(D,L lactide-glycolide) carriers.
    Chacón M; Molpeceres J; Berges L; Guzmán M; Aberturas MR
    Eur J Pharm Sci; 1999 May; 8(2):99-107. PubMed ID: 10210732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.